Process evaluation of the ‘Lafiyan Yara’ project on enhancing access to HIV testing services using existing community structures in Nigeria

by Olujide Arije, Rachel Titus, Idowu Omisile, Aisha Dadi, Danjuma Garba, Omoregie Godpower, Jennifer Anyanti, Omokhudu Idogho, Emeka Okeke, Carmen Roebersen, Eliane Vrolings, Adedeji Onayade
Published 2024-02-01

Combination prevention package of interventions for reducing vulnerability to HIV among adolescent girls and young women in Nigeria: An action research

by Olujide Arije, Ekerette Udoh, Kayode Ijadunola, Olusegun Afolabi, Joshua Aransiola, Godpower Omoregie, Oyebukola Tomori-Adeleye, Obiarairiuku Ukeme-Edet, Oluwole Fajemisin, Rachel Titus, Adedeji Onayade
Published 2023-01-01

Effectiveness of community mobilisation models in improving HIV testing services uptake among women and children in Nigeria: A quasi-experimental study

by Olujide Arije, Rachel Titus, Akintayo Olaniran, Aisha Dadi, Danjuma Garba, Emeka Okeke, Omoregie Godpower, Jennifer Anyanti, Omokhudu Idogho, Carmen Roebersen, Eliane Vrolings, Adedeji Onayade
Published 2023-01-01

Local Epidemiology of Nosocomial <i>Staphylococcus aureus</i> Infection in a Nigerian University Teaching Hospital

by Adeniran Adeyanju, Frieder Schaumburg, Adedeji Onayade, Akinyele Akinyoola, Taofeeq Adeyemi, Osaretin Ugbo, Robin Köck, Yemisi Amusa, Oladejo Lawal, Temilade Adeyanju, Nkem Torimiro, David Akinpelu, Deboye Kolawole, Christian Kohler, Karsten Becker
Published 2022-10-01

Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised...

by Adeniyi Olagunju, Adeola Fowotade, Ajibola Olagunoye, Temitope Olumuyiwa Ojo, Bolanle Olufunlola Adefuye, Adeniyi Francis Fagbamigbe, Akindele Olupelumi Adebiyi, Omobolanle Ibitayo Olagunju, Olabode Taiwo Ladipo, Abdulafeez Akinloye, Babatunde Ayodeji Adeagbo, Adedeji Onayade, Oluseye Oladotun Bolaji, Christian Happi, Steve Rannard, Andrew Owen
Published 2021-01-01

A randomized, open-label trial of combined nitazoxanide and atazanavir/ritonavir for mild to moderate COVID-19

by Adeola Fowotade, Folasade Bamidele, Boluwatife Egbetola, Adeniyi F. Fagbamigbe, Babatunde A. Adeagbo, Bolanle O. Adefuye, Ajibola Olagunoye, Temitope O. Ojo, Akindele O. Adebiyi, Omobolanle I. Olagunju, Olabode T. Ladipo, Abdulafeez Akinloye, Adedeji Onayade, Oluseye O. Bolaji, Steve Rannard, Christian Happi, Andrew Owen, Adeniyi Olagunju
Published 2022-09-01